Valeant, ex-executives face criminal probe: report
US criminal prosecutors could bring fraud charges in the coming weeks against Valeant Pharmaceuticals International and two former senior executives, Bloomberg News reported Monday. The Department of Justice probe concerns Valeant's hidden ties with Philidor RX Services, a specialty pharmacy company that Valeant secretly controlled, said the Bloomberg report, which cited unnamed people familiar with the matter. Investigators are also focusing on former chief executive J. Michael Pearson and former chief financial officer Howard Schiller, the report said.